Screening for hepatitis B, hepatitis C and HIV using a dried blood spot

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project uses dried blood spot sampling to screen for hepatitis B, hepatitis C, and HIV among people with current or past injection or nasal drug use and people on opioid substitution therapy. Capillary blood is collected onto filter paper and sent for laboratory testing for viral markers, enabling testing outside standard phlebotomy settings. Individuals with known active viral infections are excluded so the focus is on finding undiagnosed infections. The approach aims to improve reach of screening within addiction services and community sites in Normandy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Former or active intravenous and/or nasal drug user
* Person on opiate substitution therapy

Exclusion Criteria:

* Person with known active viral infection(s)

Where it's running

• Caarud Sud Manche
  Avranches, France Recruiting
• Csapa Barentin
  Barentin, France Recruiting
• Oeuvre Normande Des Meres
  Dieppe, France Recruiting
• Csapa Act
  Elbeuf, France Recruiting
• Csapa Gisors
  Gisors, France Recruiting
• Csapa Nautilia
  Le Havre, France Recruiting

Study contacts

• Principal investigator: Ghassan RIACHI, MD — University Hospital, Rouen
• Study coordinator: Ghassan RIACHI, MD
• Email: ghassan.riachi@chu-rouen.fr
• Phone: +3323288

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Achieving a functional cure for hepatitis B in patients with HIV and hepatitis B co-infection

  This study is testing if adding interferon to standard HIV treatment can help people who have both HIV and hepatitis B clear the virus from their system.

  Recruiting Guangzhou 8th People's Hospital · Guangzhou, Guangdong · NCT05988879

• Collecting blood samples from healthy individuals and patients with cancer or benign diseases

  This study is collecting blood samples from healthy people and patients with cancer or non-cancer conditions to see if certain DNA markers can help detect cancer more accurately.

  Recruiting at 6 sites Helio Genomics · Redondo Beach, California and 6 other locations · NCT05181826

• How chronic liver diseases connect with other long-term illnesses

  We will look back at hospital records to see if chronic liver diseases are linked with other systemic illnesses in adults who visited Tzu Chi gastroenterology clinics.

  Recruiting Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation · New Taipei City · NCT04525833

• Biorepository for liver disease samples

  This study is collecting samples from patients with liver diseases to help researchers find better treatments and improve care for these conditions.

  Recruiting State University of New York at Buffalo · Buffalo, New York · NCT03025074

• Evaluation of patients with liver disease

  This study is trying to learn more about liver diseases by checking in on patients with conditions like hepatitis B, C, and D through regular tests and follow-ups.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT00001971

• Entecavir 0.5 mg vs 1.0 mg daily in adults with HBV-related decompensated cirrhosis

  This trial tests whether 0.5 mg or 1.0 mg of entecavir once daily can better lower HBV DNA in adults with HBV-related decompensated cirrhosis over 24 weeks.

  Recruiting Phase 4 Bangladesh Medical University · Dhaka, Dhaka Division · NCT07816094

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.